(Q44275198)

1 December 2017

title

Warfarin and acetaminophen interaction (English)

1 reference

1 December 2017

1 reference

1 reference

Markus G Gebauer

1

1 reference

1 December 2017

Karin Nyfort-Hansen

series ordinal

2

1 reference

1 December 2017

Philip J Henschke

series ordinal

3

1 reference

1 December 2017

Alexander S Gallus

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

volume

23

1 reference

1 December 2017

issue

1

1 reference

1 December 2017

page(s)

109-112

1 reference

Prevalence of atrial fibrillation and eligibility for anticoagulants in the community

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Hydroxylation of warfarin by human cDNA-expressed cytochrome P-450: a role for P-4502C9 in the etiology of (S)-warfarin-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Inhibition of CYP2C9 by selective serotonin reuptake inhibitors: in vitro studies with tolbutamide and (S)-warfarin using human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Enzymatic shunting: resolving the acetaminophen-warfarin controversy

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Clinical pharmacokinetics of paracetamol

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Acetaminophen causes an increased International Normalized Ratio by reducing functional factor VII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Interaction between paracetamol and coumarin anticoagulants

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Acetaminophen and risk factors for excess anticoagulation with warfarin

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

The mechanism of the interaction between amiodarone and warfarin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

Potentiation of the acenocoumarol anticoagulant effect by acetaminophen

21 January 2018

1 reference

https://api.crossref.org/works/10.1592%2FPHCO.23.1.109.31913

10.1592/PHCO.23.1.109.31913

21 January 2018

Identifiers

DOI

1 reference

1 December 2017

1 reference